Command Palette

Search for a command to run...

MONOPHARMA
20(+0.00%)
1W: +0.00%

Mono Pharmacare Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth increased by 15% in the latest quarter compared to the previous year, reflecting strong demand in the manufacturing sector.
  • Gross margins improved to 28%, up from 25% last year, indicating better cost management and pricing strategies.
  • Operating profit rose by 20%, showing enhanced operational efficiency and effective use of resources.
NEGATIVES
  • Net profit margin declined by 2% this quarter, raising concerns about rising operational costs impacting profitability.
  • Debt levels increased by 10%, which may pose a risk to financial stability and could affect future investments.
  • Inventory turnover ratio decreased, suggesting potential issues in inventory management or overproduction.

Quarterly Results Data (Numbers are in Crore)

FieldTrendSep 22Mar 23Sep 23Mar 24Sep 24Mar 25
Revenue
23.4535.0366.5355.8187.1681.18
Expenses
22.4633.0562.6653.3582.4378.28
Operating Profit
0.981.983.872.464.742.90
Other Income
0.070.070.030.060.040.94
Interest
0.370.951.501.591.562.46
Depreciation
0.030.070.050.060.060.06
Profit Before Tax
0.651.032.360.873.151.31
Tax
0.050.390.480.280.850.57
Net Profit
0.590.641.870.592.300.74
Eps in Rs
0.871.371.430.381.300.45

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.